T. Beard

发表

Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial.

Sam S. Chang, R. Karnes, W. Sexton, 2014, European urology.

Association of surgical care practices with length of stay and use of clinical protocols after elective bowel resection: results of a national survey.

A. Senagore, C. Delaney, K. Tomaszewski, 2010, American journal of surgery.

The Opioid Component of Delayed Gastrointestinal Recovery After Bowel Resection

J. Leslie, Jeffrey Nemeth, T. Beard, 2011, Journal of Gastrointestinal Surgery.

Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial.

Sam S. Chang, R. Karnes, W. Sexton, 2014, The Journal of urology.

1870 ALVIMOPAN, A PERIPHERALLY ACTING MU-OPIOID RECEPTOR ANTAGONIST, ACCELERATES GASTROINTESTINAL RECOVERY AND DECREASES LENGTH OF HOSPITAL STAY AFTER RADICAL CYSTECTOMY

Sam S. Chang, R. Karnes, W. Sexton, 2013 .

Oliceridine is Associated with Reduced Risk of Vomiting and Need for Rescue Antiemetics Compared to Morphine: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials

M. Demitrack, K. Candiotti, E. Viscusi, 2020, Pain and Therapy.

Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats.

K. Hostetler, C M McCloud, T L Beard, 1996, Toxicology.

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy

S. Bergese, S. Mace, H. Minkowitz, 2019, Journal of pain research.

In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages.

C M McCloud, T L Beard, S Kacew, 1995, Experimental and molecular pathology.